Hester Bios

50
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE782E01017
  • NSEID: HESTERBIO
  • BSEID: 524669
INR
2,531.25
421.85 (20.0%)
BSENSE

Jul 13, 02:49 PM

BSE+NSE Vol: 4.27 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
332.00
311.00
304.00
266.00
235.00
214.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
332.00
311.00
304.00
266.00
235.00
214.00
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
6.00
8.00
-5.00
-10.00
3.00
Raw Materials Consumed
86.00
81.00
87.00
82.00
75.00
46.00
Power & Fuel Cost
11.00
13.00
15.00
12.00
10.00
7.00
Employee Cost
62.00
62.00
64.00
56.00
45.00
38.00
Operating Expenses
18.00
16.00
16.00
9.00
7.00
6.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
27.00
28.00
25.00
26.00
17.00
15.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
15.00
9.00
5.00
5.00
6.00
7.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
245.00
250.00
250.00
215.00
175.00
145.00
Operating Profit (PBDIT) excl Other Income
86.00
61.00
53.00
50.00
59.00
68.00
Other Income
9.00
3.00
10.00
15.00
13.00
4.00
Operating Profit (PBDIT)
96.00
64.00
64.00
65.00
73.00
73.00
Interest
10.00
12.00
19.00
9.00
4.00
6.00
Profit before Depriciation and Tax
85.00
52.00
44.00
56.00
69.00
66.00
Depreciation
18.00
16.00
17.00
20.00
16.00
13.00
Profit Before Taxation & Exceptional Items
66.00
35.00
27.00
35.00
53.00
53.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
75.00
39.00
31.00
40.00
53.00
50.00
Provision for Tax
18.00
10.00
10.00
12.00
14.00
15.00
Profit After Tax
51.00
24.00
16.00
23.00
39.00
34.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
237.00
215.00
203.00
184.00
154.00
125.00
Profit Available for appropriations
292.00
242.00
221.00
211.00
193.00
159.00
Appropriations
292.00
242.00
221.00
211.00
193.00
159.00
Equity Dividend (%)
110.00%
70.00%
60.00%
80.00%
100.00%
100.00%
Earnings Per Share
67.57
33.89
24.88
32.96
46.41
40.79
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 6.91% vs 2.15% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 41.94% vs 13.79% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -13.93% vs -35.76% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 106.71% vs 49.34% in Mar 2025

Compare Profit and Loss Results of Hester Bios
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
332.00
368.00
-36.00
-9.78%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
332.00
368.00
-36.00
-9.78%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
0.00
-4.00
0%
Raw Materials Consumed
86.00
182.00
-96.00
-52.75%
Power & Fuel Cost
11.00
26.00
-15.00
-57.69%
Employee Cost
62.00
55.00
7.00
12.73%
Operating Expenses
18.00
47.00
-29.00
-61.70%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
27.00
3.00
24.00
800.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
15.00
5.00
10.00
200.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
245.00
333.00
-88.00
-26.43%
Operating Profit (PBDIT) excl Other Income
86.00
34.00
52.00
152.94%
Other Income
9.00
8.00
1.00
12.50%
Operating Profit (PBDIT)
96.00
43.00
53.00
123.26%
Interest
10.00
3.00
7.00
233.33%
Profit before Depriciation and Tax
85.00
40.00
45.00
112.50%
Depreciation
18.00
12.00
6.00
50.00%
Profit Before Taxation & Exceptional Items
66.00
27.00
39.00
144.44%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
75.00
27.00
48.00
177.78%
Provision for Tax
18.00
6.00
12.00
200.00%
Profit After Tax
51.00
21.00
30.00
142.86%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
237.00
257.00
-20.00
-7.78%
Profit Available for appropriations
292.00
278.00
14.00
5.04%
Appropriations
292.00
278.00
14.00
5.04%
Equity Dividend (%)
110%
35%
75.00
Earnings Per Share
67.57
34.19
33.38
97.63%
Profit And Loss - Net Sales
Net Sales 332.60 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 6.91% vs 2.15% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 86.66 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 41.94% vs 13.79% in Mar 2025

Profit And Loss - Interest
Interest 10.93 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -13.93% vs -35.76% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 51.11 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 106.71% vs 49.34% in Mar 2025